Cell-Based Assay Market: Global Industry Trends, Share, Growth, Size, Region and Forecast Till 2023

Copyright © IMARC Service Pvt Ltd. All Rights Reserved

About IMARC Group

Report Description

IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations.

Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Cell-Based Assay Market Report By Technology (Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening and Others), Application (Drug Discovery, Basic Research, ADME Studies, Predictive Toxicology and Others ), End-User, Product and Services, Region The global cell-based assay market has witnessed a moderate growth over the past several years. This can be attributed to the increasing government support coupled with the development of new technologies by the manufacturers.

Market Overview: The latest report by IMARC Group, titled “Cell-Based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023�, finds that the global cell-based assay market reached a value of around US$ 13.2 Billion in 2017. Cell-based assay is an analytical method used to determine the concentration of a substance by observing their effects on living organisms (in vivo) or tissues (in vitro). It plays an important role in monitoring environmental pollutants, testing cytotoxicity and developing new drugs. Cell-based assay is often used to evaluate numerous biochemical, functional and biological effects including gene activation, cell signaling, cell proliferation, antibodydependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), apoptosis and necrosis. Over the past few years, cell-based assay has been more frequently utilized for drug discovery as it saves time and money.

Report Description and Highlights

Report Description Market Trends:

Cell-based assays are used in a broad range of applications including detection of viral contamination, screening for antimicrobial and antiviral compounds, and evaluating toxic and non-toxic substances.

For instance, cell-based assays are highly useful in screening mutagenesis in cancers like chronic myeloid leukemia. These assays are also used in the drug discovery process owing to their numerous advantages including miniaturization, multiplexing and predictability; the possibility of automation; and the ability to check for drug stability, purification and potency. Besides this, with rising government support and growing availability of funds for research, cell-based assays are being widely used by biotechnology and pharmaceutical companies to develop therapeutics for life-threatening and neurodegenerative diseases. Moreover, the development of new technologies by the manufacturers, such as advanced detection technologies and 3D cell-based assays, are providing them with lucrative opportunities in untapped markets. Looking forward, the market is projected to reach a value of US$ 21.1 Billion by 2023, exhibiting a CAGR of around 8% during 2018-2023.

Cell Based Assay Market Segmentation: Market Segmentation by Product and Services Request for a sample report: https://www.imarcgroup.com/request?type=report&id=1079&flag=B

Market Forecast

Sample Figure: Global: Cell-Based Assay Market Forecast: Sales Value (in Billion US$), 2018-2023

184.3

191.7

199.3

207.3

2018

2019

2020

2021

215.6

224.2

2022

2023

Market Segmentation

Report Description •

•

• •

Consumables o Reagents and Media o Cells and Cell Lines o Probes and Labels Instruments o Microplates o Microplate Readers o High Throughput Screening o Liquid Handling Systems Services Software

Based on products, the market has been segregated into consumables, instruments, services and software. Amongst these, consumables are the most popular product in the global cell-based assay market.

Market Breakup by Technology •

Automated Handling

For more information, click here: https://www.imarcgroup.com/cell-based-assays-market

Market Segmentation

Report Description • • • •

Flow Cytometry Label-Free Detection High-Throughput Screening Others

On the basis of technologies, automated handling dominates the market, followed by flow cytometry, label-free-detection, high-throughput screening and others.

Market Segmentation by Region • • • • •

North America Europe Asia Pacific Latin America Middle East and Africa

Region-wise, North America enjoys the leading position in the global cell-based assay market. Other major regions are Europe, Asia Pacific, Middle East and Africa, and Latin America.

Market Segmentation by Application

Regional Segmentation

North America

Europ e

Asia- Pacific

Latin America

Middle East and Africa

Market Segmentation

Report Description • • • • •

Drug Discovery Basic Research ADME Studies Predictive Toxicology Others

Based on applications, drug discovery represents the largest application segment, accounting for the majority of the global share. Drug discovery is followed by basic research, ADME studies, predictive toxicology and others.

Market Breakup by End-User Pharmaceutical and Biotechnology Companies Academic and Government Institutions Contract Research Organizations Others The market has also been segregated on the basis of end-users into pharmaceutical and biotechnology companies, academic and government institutions and contract research organizations. Currently, pharmaceutical and biotechnology companies are the largest end-user.

Market Segmentation

Report Description Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players.

• • • • • • • • • • • • • • • •

Becton Dickinson Danaher Corporation Thermo Fisher Scientific Inc. General Electric Company Merck KGaA Perkinelmer, Inc. Charles River Laboratories, Inc. Lonza Group Ltd. Cell Signaling Technology, Inc. Promega Corporation Cisbio Bioassays Cell Biolabs, Inc. Discoverx Corporation Bio-Rad Laboratories, Inc. Corning, Inc. Hoffmann-La Roche Ltd

Market Segmentation

Report Description

In case you have a very specific customized or specific niche needs, we can work around the scope of work and assist you with the tailor made solution. The topics covered could be technology, markets, competition, pricing trends, P&L analysis, cost analysis, price bench marking or it could also be supplementing you with the weekly or fortnight reports.

Team Profile

Team Profile Our Team Comes From Some of the Top Universities Globally.

60% Engineering and Science

5% Others

35% Business Studies

Over 2000 Independent Consultants from different sectors.

Average Experience of 7+ Years

A partial List of

We are the trusted business partners to the

Clients world's leading corporates, governments, and ourPartial ClientsList of institutions

A partial List of

We are the trusted business partners to the

of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions

Report Description and Highlights

Report Description

Š 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com